Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
The return on assets (ROA) is N/A as of the fiscal period ended Thursday, April 30, 2026.
Reported quarterly return on assets; no daily interpolation. Q1 FY2027 (2026-07-31): -84.89%.
RETURN ON ASSETS (ROA)
N/A
RETURN ON ASSETS (ROA) AVG TTM
-103.86%
RETURN ON ASSETS (ROA) AVG 3Y
-117.64%
RETURN ON ASSETS (ROA) AVG 5Y
-138.14%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
HeartSciences Inc.
Market Cap
$8.14M
Return on Assets (ROA)
N/A
TTM Avg
-103.86%
3Y Avg
-117.64%
5Y Avg
-138.14%
Market Cap
$8.05M
Return on Assets (ROA)
-269.47%
TTM Avg
-172.22%
3Y Avg
-300.06%
5Y Avg
-300.06%
Market Cap
$8.04M
Return on Assets (ROA)
-381.53%
TTM Avg
-330.40%
3Y Avg
-209.86%
5Y Avg
-253.27%
Market Cap
$8.33M
Return on Assets (ROA)
-23.11%
TTM Avg
-173.03%
3Y Avg
-145.25%
5Y Avg
-97.33%
Market Cap
$7.92M
Return on Assets (ROA)
86.37%
TTM Avg
-66.33%
3Y Avg
-66.09%
5Y Avg
-69.89%
Market Cap
$7.87M
Return on Assets (ROA)
-29.10%
TTM Avg
-66.56%
3Y Avg
-142.45%
5Y Avg
-115.37%
Market Cap
$7.75M
Return on Assets (ROA)
-76.12%
TTM Avg
-177.28%
3Y Avg
-394.98%
5Y Avg
-300.85%
Market Cap
$7.67M
Return on Assets (ROA)
-74.50%
TTM Avg
-220.41%
3Y Avg
-182.97%
5Y Avg
-158.82%
Market Cap
$7.64M
Return on Assets (ROA)
-106.57%
TTM Avg
-92.47%
3Y Avg
-315.20%
5Y Avg
-267.86%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HeartSciences Inc. (HSCS) | $8.14M | N/A | -103.86% | -117.64% | -138.14% |
| DataMEDS AI, Inc. (MEDS)vs › | $8.05M | -269.47% | -172.22% | -300.06% | -300.06% |
| GT Biopharma, Inc. (GTBP)vs › | $8.04M | -381.53% | -330.40% | -209.86% | -253.27% |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.33M | -23.11% | -173.03% | -145.25% | -97.33% |
| Traws Pharma, Inc. (TRAW)vs › | $7.92M | 86.37% | -66.33% | -66.09% | -69.89% |
| Aprea Therapeutics, Inc. (APRE)vs › | $7.87M | -29.10% | -66.56% | -142.45% | -115.37% |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.75M | -76.12% | -177.28% | -394.98% | -300.85% |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.67M | -74.50% | -220.41% | -182.97% | -158.82% |
| Mangoceuticals, Inc. (MGRX)vs › | $7.64M | -106.57% | -92.47% | -315.20% | -267.86% |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $8.82M | -6.36% | -31.97% | -31.64% | -61.82% |
ROA
N/A
ROE
N/A
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2026-04-30 | -0.17% |
| 2025-04-30 | -207.56% |
| 2024-04-30 | -69.51% |
| 2023-04-30 | -193.30% |
| 2022-04-30 | -231.08% |
| 2021-04-30 | -127.23% |
| 2020-04-30 | -194.86% |
